Moldova Gets Help To Join EU Medicines Network As Equal Partner
Executive Summary
The EU is funding a €1.1m project to help Moldova improve its regulatory capacity so that it is on the same footing as medical product regulators in the EU member states. The project builds on a 2014 “association agreement” signed between Moldova and the EU under plans to gradually integrate the south east European candidate country in the EU's internal market.
You may also be interested in...
Estonia helps Moldova get up to speed on EU drug requirements
Moldovan drug regulators are being brought up to speed on the EU requirements relating to authorizing medicines, inspections and pharmacovigilance from their counterparts in Estonia1,2.
Fees, GMP, clinical trials, PIC/S and more: Moldova shakes things up for entry into EU pharma space
The Republic of Moldova took a step forward in its pursuit of EU membership in June, when it signed an association agreement with the union. Alexandru Coman, director general of Moldova's Medicines and Medical Devices Agency, tells Neena Brizmohun why he is confident that his organization will soon be able to function at the level of any EU medicines regulatory body.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.